Message from the Chairman and CEO
Testing is an essential part of maintaining health by diagnosing illnesses along with healthcare.
Since its establishment in 1968, Sysmex has been providing customers around the world with the solutions that enable in vitro testing of blood and urine samples.
In addition to the fields of hematology, immunochemistry and hemostasis, we have expanded our business to include the life science domain. We are now an integrated manufacturer, developing and manufacturing the instruments, reagents and software that are needed for in vitro diagnostics and providing sales and support service networks, supporting human health in more than 190 countries and regions around the world.
Recent years have seen aging populations and increasingly diverse healthcare needs in advanced countries, and growing populations and rapid progress in healthcare infrastructures in emerging markets.
Against this backdrop, testing has increased in importance, owing to its role in disease prevention and healthcare.
In this environment, we are leveraging the technologies and knowhow we have cultivated in the in vitro diagnostics field toward the realization of healthcare optimized for individual patients. We are focused on creating new testing and diagnostic technologies to study genes, cells and proteins in the blood.
February 2018 marked Sysmex’s 50th anniversary of establishment. I would like to offer my thanks for your support to date. We will continue taking on the challenge of creating high-value testing and diagnostic technologies to contribute to the development of healthcare and the healthy lives of people.